These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38352442)

  • 1. Microbiota-Short Chain Fatty Acid Relationships and Microbial Substrate Preferences Vary Across the Spectrum of Irritable Bowel Syndrome (IBS).
    Shin A; Xing Y; Waseem MR; Siwiec R; James-Stevenson T; Rogers N; Bohm M; Wo J; Lockett C; Gupta A; Gupta A; Kadariya J; Toh E; Anderson R; Xu H; Gao X
    medRxiv; 2024 Feb; ():. PubMed ID: 38352442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome.
    Fredericks E; Theunissen R; Roux S
    Turk J Gastroenterol; 2020 Dec; 31(12):840-847. PubMed ID: 33625995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
    Jacobs JP; Lagishetty V; Hauer MC; Labus JS; Dong TS; Toma R; Vuyisich M; Naliboff BD; Lackner JM; Gupta A; Tillisch K; Mayer EA
    Microbiome; 2023 Jan; 11(1):5. PubMed ID: 36624530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation.
    Phan J; Nair D; Jain S; Montagne T; Flores DV; Nguyen A; Dietsche S; Gombar S; Cotter P
    mSystems; 2021 Dec; 6(6):e0121521. PubMed ID: 34726487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
    Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.
    Gargari G; Taverniti V; Gardana C; Cremon C; Canducci F; Pagano I; Barbaro MR; Bellacosa L; Castellazzi AM; Valsecchi C; Tagliacarne SC; Bellini M; Bertani L; Gambaccini D; Marchi S; Cicala M; Germanà B; Dal Pont E; Vecchi M; Ogliari C; Fiore W; Stanghellini V; Barbara G; Guglielmetti S
    Environ Microbiol; 2018 Sep; 20(9):3201-3213. PubMed ID: 29749705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet and gut microbial associations in irritable bowel syndrome according to disease subtype.
    Wang Y; Ma W; Mehta R; Nguyen LH; Song M; Drew DA; Asnicar F; Huttenhower C; Segata N; Wolf J; Spector T; Berry S; Staller K; Chan AT
    Gut Microbes; 2023 Dec; 15(2):2262130. PubMed ID: 37786251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Fecal Short Chain Fatty Acids With Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome.
    Waseem MR; Shin A; Siwiec R; James-Stevenson T; Bohm M; Rogers N; Wo J; Waseem L; Gupta A; Jarrett M; Kadariya J; Xu H
    Clin Transl Gastroenterol; 2023 Jan; 14(1):e00541. PubMed ID: 36227781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
    Xiao L; Liu Q; Luo M; Xiong L
    Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome.
    Wang T; Rijnaarts I; Hermes GDA; de Roos NM; Witteman BJM; de Wit NJW; Govers C; Smidt H; Zoetendal EG
    Dig Dis Sci; 2022 Nov; 67(11):5137-5148. PubMed ID: 35624331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes.
    Villanueva-Millan MJ; Leite G; Wang J; Morales W; Parodi G; Pimentel ML; Barlow GM; Mathur R; Rezaie A; Sanchez M; Ayyad S; Cohrs D; Chang C; Rashid M; Hosseini A; Fiorentino A; Weitsman S; Chuang B; Chang B; Pichetshote N; Pimentel M
    Am J Gastroenterol; 2022 Dec; 117(12):2055-2066. PubMed ID: 36114762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

  • 15. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids.
    Sagar NM; Duboc H; Kay GL; Alam MT; Wicaksono AN; Covington JA; Quince C; Kokkorou M; Svolos V; Palmieri LJ; Gerasimidis K; Walters JRF; Arasaradnam RP
    Sci Rep; 2020 Nov; 10(1):20436. PubMed ID: 33235223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.
    Choo C; Mahurkar-Joshi S; Dong TS; Lenhart A; Lagishetty V; Jacobs JP; Labus JS; Jaffe N; Mayer EA; Chang L
    Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G134-G143. PubMed ID: 35726867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota participates in the effect of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a multicenter, prospective, pre-post study.
    Zhou J; Wei H; Zhou A; Xiao X; Xie X; Tang B; Lin H; Tang L; Meng R; Yuan X; Zhang J; Huang C; Huang B; Liao X; Zhong T; He S; Gu S; Yang S
    J Transl Med; 2024 Jan; 22(1):98. PubMed ID: 38263117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet.
    Vervier K; Moss S; Kumar N; Adoum A; Barne M; Browne H; Kaser A; Kiely CJ; Neville BA; Powell N; Raine T; Stares MD; Zhu A; De La Revilla Negro J; Lawley TD; Parkes M
    Gut; 2022 Sep; 71(9):1821-1830. PubMed ID: 34810234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.
    Treem WR; Ahsan N; Kastoff G; Hyams JS
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):280-6. PubMed ID: 8890079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.